Executive Director
Endocrinology
Dr. Richard M. Bergenstal, MD
|
|
Give Review
Doctor Richard M. Bergenstal, MD works in the field of Endocrinology. He went to medical school at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care Richard Bergenstal is also published. He has 98 publications published. The lastest publication: "The insulin sliding scale is not dead.' He accepts all Medicare patients.
Publications
- Recurrent Endocrine Cycles.
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
- Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs: A Joint Statement of the European Associat...
- Response to Comment on Wong et al. Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37:2702-2709.
- Management of hyperglycaemia in type 2 Diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European...
- Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Associati...
- LEADER 2: baseline calcitonin in 9340 people with type 2 Diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Resul...
- LEADER 3-Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial.
- Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry.
- Depression in Adults in the T1D Exchange Clinic Registry.
- Application of PK/PD Modeling and Simulation to Dosing Regimen Optimization of High-Dose Human Regular U-500 Insulin.
- Design of the liraglutide effect and action in Diabetes: Evaluation of cardiovascular outcome results (LEADER) trial.
- Lower Glucose Variability and Hypoglycemia Measured by Continuous Glucose Monitoring With Novel Long-Acting Insulin LY2605541 Versus Insulin Glargine.
- Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry.
- Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 Diabetes: results from the T1D Exchange clinic registry.
- Threshold-based insulin-pump interruption for reduction of hypoglycemia.
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP).
- Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1C Levels in T1D Exchange Clinic Registry Participants.
- Exenatide Once Weekly Improved Glycaemic Control, Cardiometabolic Risk Factors, and a Composite Index of an HbA1c<7%, Without Weight Gain or Hypoglycaemia, Over 52 We...
- Advanced Meter Features Improve Postprandial and Paired Self-Monitoring of Blood Glucose in Individuals with Diabetes: Results of the Actions with the CONTOUR Blood G...
- The T1D Exchange clinic registry.
- Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-Diabetes: a randomized trial.
- Can a tool that automates insulin titration be a key to Diabetes management?
- A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 Diabetes.
- Management of hyperglycemia in type 2 Diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association...
- Preadmission glycemic control and changes to Diabetes mellitus treatment regimen after hospitalization.
- Management of hyperglycaemia in type 2 Diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Associatio...
- Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenati...
- EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE) A cardio...
- The safety of incretin-based therapies--review of the scientific evidence.
- Baseline Predictors of A1C Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy: The STAR 3 Experience.
- Improving blood pressure control in individuals with Diabetes: a quality improvement collaborative.
- Use of twice-daily exenatide in Basal insulin-treated patients with type 2 Diabetes: a randomized, controlled trial.
- Diabetes and cancer: a consensus report.
- Effects of exenatide combined with lifestyle modification in patients with type 2 Diabetes.
- Type 2 Diabetes: assessing the relative risks and benefits of glucose-lowering medications.
- Point: The reporting of estimated glucose With hemoglobin A1c.
- Incretin-based therapies for the treatment of type 2 Diabetes: evaluation of the risks and benefits.
- Does availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 Diabetes?
- Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.
- Clinical application of emerging sensor technologies in Diabetes management: consensus guidelines for continuous glucose monitoring (CGM).
- Adjust to target in type 2 Diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.
- A new look at screening and diagnosing Diabetes mellitus.
- Integrated practice units are bridges, not 'archipelagoes'.
- Treatment models from the International Diabetes Center: advancing from oral agents to insulin therapy in type 2 Diabetes.
- Macrovascular risk factors in patients with Diabetes: physician treatment strategies and extent of control.
- Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control.
- Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing.
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile.
- Effects of exenatide versus insulin analogues on weight change in subjects with type 2 Diabetes: a pooled post-hoc analysis.
- Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase.
- Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid u...
- DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide.
- Long-term effect of rosiglitazone and/or ramipril on the incidence of Diabetes.
- Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 Diabetes (DURATION-2): a randomised ...
- Effectiveness of sensor-augmented insulin-pump therapy in type 1 Diabetes.
- The association between symptomatic, severe hypoglycaemia and mortality in type 2 Diabetes: retrospective epidemiological analysis of the ACCORD study.
- The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiolog...
- Low cardiorespiratory fitness in people at risk for type 2 Diabetes: early marker for insulin resistance.
- A1C predicts type 2 Diabetes and impaired glucose tolerance in a population at risk: the community Diabetes prevention project.
- Comparison of insulin analogue regimens in people with type 2 Diabetes mellitus in the PREFER Study: a randomized controlled trial.
- Efficacy of inhaled insulin in patients with type 2 Diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial.
- The role of self-monitoring of blood glucose in the care of people with Diabetes: report of a global consensus conference.
- Characterizing blood pressure control in individuals with Type 2 Diabetes: the relationship between clinic and self-monitored blood pressure.
- Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material.
- Carbohydrate metabolism in pregnancy: XIII. Relationships between plasma insulin and proinsulin during late pregnancy in normal and diabetic subjects.
- Practice guidelines for nutrition care by dietetics practitioners for outpatients with non-insulin-dependent Diabetes mellitus: methodologies for field-testing and cos...
- Diabetic ketoacidosis. How to treat and, when possible, prevent.
- Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport.
- Observations on control of glycemia With conventional insulin therapy or continuous subcutaneous insulin infusion.
- Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII.
- Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy.
- Dietary practices of persons with Diabetes during insulin pump therapy.
- Azotomycin--toxicologic, biochemical and pharmacologic studies in mice.
- Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women.
- Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.
- The metabolic effects of biosynthetic human proinsulin in individuals with type I Diabetes.
- The effects of biosynthetic human proinsulin on carbohydrate metabolism.
- Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of Diabetes.
- Absence of exercise-induced hypoglycaemia in Type i (insulin-dependent) diabetic patients during maintenance of normoglycaemia by short-term, open-loop insulin infusion.
- Lack of glucagon response to hypoglycemia in Type I diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pump.
- Metabolic control and complications in diabetic patients.
- Relation of counterregulatory responses to hypoglycemia in Type I diabetics.
- Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent Diabetes mellitus: a randomized, controlled clinical trial.
- Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent Diabetes mellitus.
- Intensified Diabetes management: lessons from the Diabetes control and complications trial.
- A joint venture With the commonwealth of independent states.
- The insulin sliding scale is not dead.
- A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 Diabetes.
- Optimization of insulin therapy in patients with type 2 Diabetes.
- Use of an automated device for alternative site blood glucose monitoring.
- Comprehensive management of patients with type 2 Diabetes: establishing priorities of care.
- Identifying variables associated With inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy.
- Undetected, uncontrolled blood pressure in type 2 Diabetes: self-monitored blood pressure profiles.
- Characterizing glucose exposure for individuals With normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis.
- Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial.
- Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes trials: a position statement of the Americ...
Schools
University of Chicago
Conditions Treated
- Diabetes Type 1
- Diabetes Type 2
- Diabetes With Renal Manifestations
- Gestational Diabetes
Doctors Specialties
- Endocrinology
Accepted Insurances
Education
-
University of Chicago -
University of Chicago Pritzker School of Medicine
Drug Facts
| NPI NUMBER | 1669459061 | |
| NPPES Provider LastName | BERGENSTAL | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 554162527 | |
| NPPES Provider State | MN | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 14.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669459061 |
| Last Name Of The Provider | BERGENSTAL |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Gregory S. Damberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Tridgell, MD
This Doctor is OpenDoctor Recommended.
|